A 63-year-old previously healthy woman presented to the hospital with fever, breathlessness, and abdominal pain for 6 days. She reported a history of successfully treated breast cancer 5 years ago (surgery and chemotherapy) and 37 pack-years of smoking. In the following days she developed a severe ARDS. Bronchoscopy showed multiple tracheal ulcerations (Fig. [1](#Fig1){ref-type="fig"}a). The performed transbronchial biopsy, BAL cultures, and PCR revealed influenza A, parainfluenza 4 virus, and an invasive aspergillus (IA) fumigatus infection (Fig. [1](#Fig1){ref-type="fig"}b). Serum aspergillus galactomannan antigen levels were 1.5 ng/mL. CTs of the thorax showed progressive bilateral cavities over the following days (Fig. [1](#Fig1){ref-type="fig"}c, d). Despite full intensive care, including antiviral and antifungal treatment, the patient died of the severe ARDS.Fig. 1**a** Multiple tracheal ulcerations on day 3. **b** Histology of lung parenchyma with invasive pulmonary aspergillosis (*arrow*). **c** CT scan of the lungs on day 4 showing bilateral alveolar and peribronchial lesions compatible with invasive aspergillosis. **d** CT scan of the lungs on day 11 showing progressive bilateral cavities

Risk factors are use of corticosteroids (CS) or smoking. However, influenza viruses have been reported to cause cell-mediated destruction of airway epithelium and disruption of normal mucociliary clearance, fostering colonization and invasion with*Aspergillus* even in immunocompetent H1N1 patients \[[@CR1]\]. The occurrence of IA in the ICU usually entails a poor prognosis. Therefore, our threshold to actively search for invasive aspergillosis in critically ill influenza patients should be low. Only early diagnosis and treatment might improve the high mortality rate.
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